Argireline: Molecular Structure

Molecular Structure#

Argireline (acetyl hexapeptide-8) has the molecular formula C34H60N14O12S and a molecular weight of approximately 889 Da. The full chemical name describes an acetylated hexapeptide with the sequence Glu-Glu-Met-Gln-Arg-Arg bearing a C-terminal amide group.

Amino Acid Sequence#

Sequence: Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2 (Ac-EEMQRR-NH2)

This six-amino acid sequence was rationally designed to mimic the N-terminal region of SNAP-25 (residues 12-17). SNAP-25 is a 206-amino acid protein that is an essential component of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex, which drives synaptic vesicle fusion and neurotransmitter release.

Design Rationale#

The N-terminal domain of SNAP-25 is involved in the initial binding and assembly of the SNARE ternary complex. By mimicking this region, Argireline competes with endogenous SNAP-25 for SNARE complex binding sites, effectively destabilizing complex formation.

Key design features:

• Acetylation (N-terminal): Protects against aminopeptidase degradation and mimics the native acetylation state
• Amidation (C-terminal): Protects against carboxypeptidase degradation and improves membrane interaction
• Glutamate residues (E-E): Provide negative charge for electrostatic interactions with SNARE partners
• Methionine (M): Maintains structural similarity to the native SNAP-25 sequence
• Arginine residues (R-R): Contribute positive charge and hydrogen bonding capacity

Chemical Properties#

Skin Penetration Challenge#

A significant limitation of Argireline is its hydrophilic nature and molecular size. Effective topical delivery requires the peptide to penetrate the lipid-rich stratum corneum to reach the dermal-epidermal junction and underlying neuromuscular targets. Various formulation strategies have been explored to enhance penetration:

• Lipid-based delivery systems (liposomes, nanoparticles)
• Chemical penetration enhancers
• Iontophoresis and microneedling-assisted delivery
• Combination with lipophilic carrier peptides

Relationship to SNAP-8#

SNAP-8 (acetyl octapeptide-3, Ac-EEMQRRAD-NH2) extends the Argireline sequence by two additional amino acids, mimicking a larger portion of the SNAP-25 N-terminus. This extended sequence may provide more effective SNARE complex interference, though direct comparative clinical data are limited.

Molecular Context#

Argireline belongs to the Cosmetic category of research peptides. The molecular properties of Argireline determine its pharmacological behavior, including receptor binding, distribution, metabolism, and elimination. Understanding these properties is fundamental to interpreting clinical data and designing research protocols.

Structural Overview#

Argireline is characterized as: Argireline is a synthetic acetylated hexapeptide with a C-terminal amide. The sequence Ac-EEMQRR-NH2 mimics the N-terminal end of SNAP-25, a key component of the SNARE complex that mediates synaptic vesicle fusion. The N-terminal acetylation and C-terminal amidation enhance stability against exopeptidases..

Amino Acid Sequence Details#

The amino acid sequence of Argireline is: Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2 (Ac-EEMQRR-NH2). This sequence determines the peptide's three-dimensional structure, receptor binding properties, and biological activity.

Pharmacokinetic Profile#

Half-Life: Topical peptide -- systemic half-life not applicable

The half-life of a peptide influences dosing frequency, duration of effect, and the clinical utility of the compound. Researchers should consider the half-life when designing experimental protocols.

Related Reading#

• Argireline overview and research guide
• Peptides similar to Argireline
• Argireline research evidence